Health
Patients with Relapsed/Refractory AML may Benefit from Treatment with Ficlatuzumab + Chemotherapy – OncoZine
Ficlatuzumab (AV-299) in combination with cytarabine (ara-C), demonstrates signs of clinical efficacy in patients with r/r AML….
Ficlatuzumab (formerly known as AV-299), a potent hepatocyte growth factor (HGF) immunoglobulin G1 (IgG1) inhibitory antibody that binds to the HGF ligand with high affinity and specificity, in combination with cytarabine (also known as arabinofuranosyl…
Continue Reading
